Taiwan FDA registration cbc157730c4fa945d5294b2b269b101f
"Telmau" new generation Vitesse endoscopic vascular retrieval system
TW: “泰爾茂”新一代維特斯內視鏡血管擷取系統
Taiwan·Risk Class 2·TERUMO CARDIOVASCULAR SYSTEMS CORPORATION·Registered Mar 18, 2013 – Mar 18, 2028ActiveRegistration details
- Analysis ID
- cbc157730c4fa945d5294b2b269b101f
- Customs Code
- DHA00602478706
Company information
- Manufacturer
- TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- TERUMO TAIWAN MEDICAL CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- H Gastroenterology and urology
- Product Type (Level 2)
- H.1500 Internal Scope and its accessories
- Import Information
- import
Dates and status
- Registration Date
- Mar 18, 2013
- Expiry Date
- Mar 18, 2028
About this record
Access comprehensive regulatory information for "Telmau" new generation Vitesse endoscopic vascular retrieval system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cbc157730c4fa945d5294b2b269b101f and manufactured by TERUMO CARDIOVASCULAR SYSTEMS CORPORATION. The authorized representative in Taiwan is TERUMO TAIWAN MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices